Clinical Trials: Non-Hodgkin's Lymphoma
We currently have a pilot Phase II approved protocol for previously untreated Stage III or IV asymptomatic, non-bulky Follicular lymphoma, ready for execution and are designing additional protocols for FL utilizing total antigenic repertoire as well as novel neo-antigens.
Proposed Principal Investigator:
Principal Investigator TBD (to be determined)
Status: Approved, not started